Theralase Technologies (TLT) News Today → Americans Now Need $1.46M to Retire… (From Crypto 101 Media) (Ad) Free TLT Stock Alerts C$0.16 -0.01 (-3.03%) (As of 05/16/2024 05:19 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 2, 2024 | finance.yahoo.comTheralase(R) Expands Clinical TeamApril 24, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Closes $CAN 750,000 Non-Brokered Private PlacementApril 5, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Granted Canadian Cancer Vaccine PatentApril 5, 2024 | finance.yahoo.comTheralase(R) Granted Canadian Cancer Vaccine PatentMarch 26, 2024 | finance.yahoo.comTheralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological AssociationMarch 16, 2024 | theglobeandmail.comClosing Bell: Theralase Technologies Inc flat on Friday (TLT)March 1, 2024 | morningstar.comTheralase Technologies Inc TLTFebruary 12, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's DiseaseFebruary 12, 2024 | finance.yahoo.comTheralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's DiseaseFebruary 8, 2024 | finance.yahoo.comDr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyFebruary 5, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Closes $CAN 1.2 Million Non-Brokered Private PlacementFebruary 5, 2024 | finance.yahoo.comTheralase(R) Closes $CAN 1.2 Million Non-Brokered Private PlacementJanuary 15, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Provides Update on Phase II Bladder Cancer Clinical StudyDecember 1, 2023 | proactiveinvestors.comTheralase makes positive progress on Phase II study on...Theralase makes positive progress on Phase II study on bladder...November 30, 2023 | proactiveinvestors.comTheralase concludes $1.17M private placement for cancer treatment advancementsNovember 30, 2023 | proactiveinvestors.comTheralase focused on breakthrough designation after positive preliminary study dataNovember 29, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Release's 3Q2023 Interim Financial StatementsNovember 29, 2023 | finance.yahoo.comTheralase Release's 3Q2023 Interim Financial StatementsNovember 29, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Closes $CAN 1.17 Million Non-Brokered Private PlacementNovember 17, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Commences Non-Brokered Private Placement and Termination of Previously Announced FinancingNovember 17, 2023 | finance.yahoo.comTheralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced FinancingOctober 23, 2023 | benzinga.comTheralase(R) Announces Brokered LIFE FinancingOctober 23, 2023 | finance.yahoo.comTheralase(R) Optimizes Phase II Bladder Cancer Clinical StudyOctober 16, 2023 | finance.yahoo.comTheralase(R) Provides Update on Bladder Cancer Clinical StudyOctober 10, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT up on Friday (TLT-WT)October 5, 2023 | finance.yahoo.comTheralase(R) Files US Patent for Enhanced ImmunotherapySeptember 29, 2023 | finance.yahoo.comTheralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)September 29, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Demonstrates 8 Year Shelf Life of Lead Drug RuvidarSeptember 27, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Successfully Completes Non-GLP Toxicity Analysis for Brain CancerSeptember 27, 2023 | finance.yahoo.comTheralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain CancerSeptember 21, 2023 | finance.yahoo.comTheralase(R) Grants Stock OptionsSeptember 7, 2023 | finance.yahoo.comTheralase(R) Closes Private Placement Equity FinancingSeptember 5, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc up on Tuesday (TLT)August 29, 2023 | investing.comTheralase Technologies (TLT) Earnings Dates & ReportsAugust 29, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Release's 2Q2023 Interim Financial StatementsAugust 29, 2023 | finance.yahoo.comTheralase Release’s 2Q2023 Interim Financial StatementsAugust 25, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT flat on Thursday (TLT-WT)August 24, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT up on Tuesday (TLT-WT)August 22, 2023 | seekingalpha.comTLT:CA Theralase Technologies Inc.August 21, 2023 | finance.yahoo.comTheralase Technologies Inc. (TLTFF)August 21, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc up on Monday (TLT)July 29, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT down on Thursday (TLT-WT)July 19, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc flat on Tuesday (TLT)July 18, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT down on Monday (TLT-WT)June 30, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Closes Non-Brokered Private Placement Equity FinancingJune 30, 2023 | finance.yahoo.comTheralase(R) Closes Non-Brokered Private Placement Equity FinancingJune 22, 2023 | theglobeandmail.comClosing Bell: Theralase Technologies Inc WT flat on Wednesday (TLT-WT)May 30, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial StatementsMay 30, 2023 | finanznachrichten.deTheralase Technologies Inc.: Theralase Releases 1Q2023 Interim Financial StatementsMay 30, 2023 | finance.yahoo.comTheralase(R) Releases 1Q2023 Interim Financial Statements Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher. Click here to claim your free seat ticket now. TLT Media Mentions By Week TLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLT News Sentiment▼0.000.54▲Average Medical News Sentiment TLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLT Articles This Week▼01▲TLT Articles Average Week Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VentriPoint Diagnostics News MedX Health News Aurora Spine News Profound Medical News HEXO News Charlotte's Web News Akumin News IBEX Technologies News Reliq Health Technologies News MediPharm Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TLT) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theralase Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
